EDIT:NASDAQ
Editas Medicine Inc
1,73 US$
arrow_upward
+1,17%(+0,020) 1K
20-noy, 11:30:32 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
1,69 US$
Yuqori
1,78 US$
Past
1,66 US$
Bozor kapitali
267,01 mln
Oʻrtacha hajm
2,24 mln
Hajmi
577,56 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
1,69 US$
Yuqori
1,78 US$
Past
1,66 US$
Bozor kapitali
267,01 mln
Oʻrtacha hajm
2,24 mln
Hajmi
577,56 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Traders Union
·
2 soat oldin
Ryan Detrick: S&P 500 posts six-day losing streak, longest since April 2024
ChartMill
·
2 soat oldin
S&P 500 Premarket Movers Friday: Gainers and Losers
marketscreener.com
·
4 soat oldin
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
TradingView
·
1 soat oldin
S&P 500 is on track for the worst week since the April 2025 'Liberation Day' sell-off
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com